Pa. Appeals Court Revives Risperdal Breast Growth Case

Law360 (July 16, 2019, 6:56 PM EDT) -- A young man who claims the antipsychotic drug Risperdal caused him to grow breasts will get another shot at holding Johnson & Johnson accountable, after a Pennsylvania Superior Court on Tuesday reversed a judge's 2016 decision to torpedo his suit midtrial due to lack of evidence.

In a 35-page opinion, a three-judge panel said Judge Sean Kennedy of the Philadelphia County Court of Common Pleas got it wrong when he pulled the plug on Tommy Moroni's Risperdal trial three years ago, a stunning departure from a $70 million verdict a jury returned the same year in another Risperdal case. 

Judge Kennedy...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS